Share This Article:

Caffeine and Reactive Hyperemia

Full-Text HTML XML Download Download as PDF (Size:1049KB) PP. 437-448
DOI: 10.4236/wjcd.2019.97039    130 Downloads   250 Views

ABSTRACT

The physiological/pathophysiological effects of caffeine on the human cardiovascular system have not been investigated by physiologists and are poorly understood. In a world where caffeinated beverages are evidently the adult’s drug of choice (coffee, energy drinks, soda, tea) investigating their effects on the physiology of the cardiovascular system is of considerable importance. In this experiment, we investigated caffeine, taken orally as a tablet, on reactive hyperemia, a form of local control of blood flow. Young adults between the ages of 18 and 21 years were the experimental subjects. They were instrumented to monitor systemic arterial blood pressure, peripheral blood flow, calculated peripheral vascular resistance, heart rate and an electrocardiogram during a reactive hyperemia maneuver in the absence and presence of caffeine. Caffeine-mediated peripheral vasoconstriction was observed as early as 15 minutes after its consumption. Forty-five minutes later (60 min after consumption of caffeine) peripheral vasoconstriction was so prominent that reactive hyperemia was abolished. This was reflected, in part, as a marked and significant reduction in post-ischemia reactive hyperemia that accompanied a 2.5-fold increase in peripheral vascular resistance (P <0.05). Heart rate was unaffected by caffeine under our experimental conditions. We conclude that caffeine has the ability to inhibit important cardiovascular properties, including reactive hyperemia. If the effects that were seen in a digit are indicative of what caffeine might do in the heart and/or brain, then one has to question the wisdom of regularly consuming caffeine. More experimental physiological and pharmacological investigation is needed.

Cite this paper

Merrill, G. , Costea, D. and Sharp, V. (2019) Caffeine and Reactive Hyperemia. World Journal of Cardiovascular Diseases, 9, 437-448. doi: 10.4236/wjcd.2019.97039.

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.